Activation of NF-κB is essential for hepatocyte growth factor-mediated proliferation and tubulogenesis

Molecular and Cellular Biology

Volumn 22, Issue 4, 2002, Pages 1060-1072

  Müller, Markus ^a   Morotti, Alessandro ^a   Ponzetto, Carola ^a  

^a Dept of Anatomy ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH FACTOR; I KAPPA B; I KAPPA B ALPHA; I KAPPA B ALPHA 2A; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; REPRESSOR PROTEIN; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; UNCLASSIFIED DRUG; DNA; DNA BINDING PROTEIN; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA; ONCOPROTEIN; PROTEIN KINASE B; PROTEIN SERINE THREONINE KINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL LINE; CELL PROLIFERATION; CONTROLLED STUDY; DNA BINDING; ENZYME ACTIVATION; EPITHELIUM CELL; MORPHOGENESIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; ANIMAL; CELL DIVISION; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; LIVER; METABOLISM; PHOSPHORYLATION; PHYSIOLOGY; PROTEIN BINDING;

ANIMALIA;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL LINE; CELL MOVEMENT; DNA; DNA-BINDING PROTEINS; GENE EXPRESSION REGULATION; HEPATOCYTE GROWTH FACTOR; HUMANS; I-KAPPA B PROTEINS; LIVER; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; MORPHOGENESIS; NF-KAPPA B; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036007194     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.22.4.1060-1072.2002     Document Type: Article

References (83)

1. Phosphorylation by p44 MAP kinase/ERK1 stimulates CBP histone acetyl transferase activity in vivo
2. ras and protein kinase C in primary endothelial cells
3. Death receptors: Signaling and modulation
4. The NF-κB and IκB proteins: New discoveries and insights
5. HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death
6. Control of apoptosis by Rel/NF-κB transcription factors
7. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-kappa B
8. An essential role for NF-κB in preventing TNFα induced cell death
9. Metalloproteinase expression in normal and malignant oral keratinocytes: Stimulation of MMP-2 and -9 by scatter factor
10. IκBα degradation and nuclear factor-κB DNA binding are insufficient for interleukin-Iβ and tumor necrosis-α-induced κB-dependent transcription
11. A role for nuclear factor κb in the antiapoptotic function of insulin
12. Scatter factor and hepatocyte growth factor: Activities, properties and mechanism
13. Developmental roles of HGF/SF and its receptor, the c-Met tyrosine kinase
14. Hepatocyte growth factor (HGF) receptor expression is inducible and is part of the delayed-early response to HGF
15. Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
16. Hepatocyte growth factor: A multifunctional cytokine
17. Scatter factor/hepatocyte growth factor protects against cytotoxic death in human glioblastoma via phosphatidylinositol 3-kinase- and AKT-dependent pathways
18. Mechanisms of hepatic toxicity. I. TNFα-induced liver injury
19. The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression
20. A constitutive active MEK → ERK pathway negatively regulates NF-κB-dependent gene expression by modulating TATA-binding protein phosphorylation
21. Hepatocyte growth factor/scatter factor induces a variety of tissue specific morphogenic programs in epithelial cells
22. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation
23. Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth
24. Neu differentiation factor/heregulin induction by hepatocyte and keratinocyte growth factors
25. Kinase regulation in inflammatory response
26. Absence of tumor necrosis factor rescues RelA-deficient mice from embryonic lethality
27. The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates through NF-kappa B p50 homodimers
28. Hepatocyte growth factor-scatter factor: Mitogen, motogen and met
29. Sustained recruitment of phospholipase C-gamma to Gab-1 is required for HGF-induced branching tubulogenesis
30. NF-κB controls cell growth and differentiation through transcriptional regulation of cyclin D1
31. The epidermal growth factor receptor engages receptor interacting protein and nuclear factor-kappa b (nf-kappa b)-inducing kinase to activate nf-kappa b. Identification of a novel receptor-tyrosine kinase signalosome
32. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor κb
33. I-to-S-phase transition
34. NFκB prevents apoptosis and liver dysfunction during liver regeneration
35. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo
36. Rac1 regulates interleukin 1-induced nuclear factor Kb activation in an inhibitory protein Kbα-independent manner by enhancing the ability of the p65 subunit to transactivate gene expression
37. Hepatocyte growth factor/scatter factor, its molecular, cellular and clinical implications in cancer
38. The beginning of the end: IκB kinase (IKK) and NF-κB activation
39. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-κB and AP-1
40. Phosphoinositide 3-kinase induces scattering and tubulogenesis in epithelial cells through a novel pathway
41. Abrogation of Fas-induced fulminant hepatic failure in mice by hepatocyte growth factor
42. Functional significance of MMP-9 in tumor necrosis factor-induced proliferation and branching morphogenesis of mammary epithelial cells
43. Activation of p38 mitogen-activated protein kinase is required for tumor necrosis factor-a-supported proliferation of leukemia and lymphoma cell lines
44. Hepatocyte growth factor promotes renal epithelial cell survival by dual mechanisms
45. A phosphatidylinositol 3-kinase/Akt pathway, activated by tumor necrosis factor or interleukin-1, inhibits apoptosis but does not activate NFκB in human endothelial cells
46. Akt supresses apoptosis by stimulating the transactivation potential of the RelA/p65 subunit of NF-κB
47. Nerve growth factor-dependent activation of NF-κB contributes to survival of sympathetic neurons
48. Uncoupling of Grb2 from the Met receptor in vivo reveals complex roles in muscle development
49. Met receptor signaling is required for sensory nerve development and HGF promotes axonal growth and survival of sensory neurons
50. The Gab1 PH domain is required for localization of Gab1 at sites of cell-cell contact and epithelial morphogenesis from the Met receptor tyrosine kinase
51. Emerging multipotent aspects of hepatocyte growth factor
52. The transcription factor NF-κB: Control of oncogenesis and cancer therapy resistance
53. The tyrosine kinase receptors Ron and Sea control 'scattering' and morphogenesis of liver progenitor cells in vitro
54. A gene trap vector system for identifying transcriptionally responsive genes
55. Oncogenic ras enhances NF-κB transcriptional activity through Raf-dependent and Raf-independent mitogen-activated protein kinase signaling pathways
56. Activators and target genes of Rel/NF-κB transcriptions factors
57. The Rel/NF-κB family: Friend and foe
58. Novel inhibitors of cytokine-induced IκBα phosphorylation and endothelial cell adhesion molecule expression show anti-inflammatory effects in vivo
59. Grb2 interaction with MEK-kinase 1 is involved in regulation of Jun-kinase activities in response to epidermal growth factor
60. A multifunctional docking site mediates signaling and transformation by the hepatocyte growth factor/scatter factor receptor family
61. Met signaling mutants as tools for developmental studies
62. PDGF-induced Akt phosphorylation does not activate NF-κB in human vascular smooth muscle cells and fibroblasts
63. NF-κB is a target of AKT in anti-apoptotic PDGF signalling
64. The NF-κB activation pathway: A paradigm in information transfer from membrane to nucleus
65. Role of NF-κB in p53-mediated programmed cell death
66. Scatter factor/hepatocyte growth factor is essential for liver development
67. IκB-independent control of NF-κB activity by modulatory phosphorylations
68. Keratinocyte growth factor protects murine hepatocytes from tumor necrosis-induced apoptosis in vivo and in vivo
69. Transcriptional activation of the hepatocyte growth factor receptor (c-met) gene by its ligand (hepatocyte growth factor) is mediated through AP-1
70. Involvement of the transcription factor NF-κB in tubular morphogenesis of human microvascular endothelial cells by oxidative stress
71. Activation of phosphatidylinositol 3-kinase in response to interleukin-3 leads to phosphorylation and activation of the NF-κB p65/RelA subunit
72. Interleukin-1
73. Hepatocyte growth factor promotes cell survival from Fasmediated cell death in hepatocellular carcinoma cells via Akt activation and Fas-death-inducing signaling complex suppression
74. Suppression of TNFα induced apoptosis by NF-κB
75. p38 and extracellular signal-regulated kinase mitogen-activated protein kinase pathways are required for nuclear factor-κb p65 transactivation by tumor necrosis factor
76. Activation of nuclear factor-κB-dependent transcription by tumor necrosis factor-α is mediated through phosphorylation of RelA/p65 on serine 529
77. 529 is controlled by casein kinase II
78. Activation of transcription factor NF-κB and p38 mitogen-activated protein kinase is mediated by distinct and separate stress effector pathways
79. N- and T-terminal sequences control degradation of MAD3/IκBα in response to inducers of NF-κB activity
80. Hepatocyte growth factor increases expression of vascular endothelial growth factor and plasminogen activator inhibitor-1 in human keratinocytes and the vascular endothelial growth factor receptor flk-1 in human endothelial cells
81. NF-κB inactivation converts a hepatocyte cell line TNFα response from proliferation to apoptosis
82. Hepatocyte growth factor protects cultured rat cerebellar granule neurons from apoptosis via the phosphatidylinositol-3 kinase/Akt pathway
83. Phosphorylation of NF-κB p65 by PKA stimulates transcriptional activity by promoting a novel bivalent interaction with the coactivator CBP/p300